Gene test could revolutionize TB treatment for thousands
NCT ID NCT05553236
First seen Feb 01, 2026 · Last updated May 08, 2026 · Updated 9 times
Summary
This study tests whether a new genetic sequencing method can help doctors choose the right drugs for people with drug-resistant tuberculosis (TB). Researchers will compare standard care to the new approach in 2,500 participants across multiple clinics. The goal is to improve cure rates and reduce time on ineffective medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
South African National Health Laboratory Service
RECRUITINGCape Town, South Africa
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.